skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 47  for All Library Resources

Results 1 2 3 next page
Refined by: author/creator: Vrablik, Michal remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Homeostasis Model Assessment for Insulin Resistance Mediates the Positive Association of Triglycerides with Diabetes
Material Type:
Article
Add to My Research

Homeostasis Model Assessment for Insulin Resistance Mediates the Positive Association of Triglycerides with Diabetes

Diagnostics (Basel), 2024-04, Vol.14 (7), p.733 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2075-4418 ;EISSN: 2075-4418 ;DOI: 10.3390/diagnostics14070733 ;PMID: 38611646

Full text available

2
Genetic risk score in patients with the APOE2/E2 genotype as a predictor of familial dysbetalipoproteinemia
Material Type:
Article
Add to My Research

Genetic risk score in patients with the APOE2/E2 genotype as a predictor of familial dysbetalipoproteinemia

Journal of clinical lipidology, 2024-03, Vol.18 (2), p.e230 [Peer Reviewed Journal]

Copyright © 2023. Published by Elsevier Inc. ;ISSN: 1933-2874 ;EISSN: 1876-4789 ;DOI: 10.1016/j.jacl.2023.11.010 ;PMID: 38044203

Digital Resources/Online E-Resources

3
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
Material Type:
Article
Add to My Research

Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI

Cardiovascular drugs and therapy, 2023-10, Vol.37 (5), p.941-953 [Peer Reviewed Journal]

The Author(s) 2022 ;2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0920-3206 ;EISSN: 1573-7241 ;DOI: 10.1007/s10557-022-07343-x ;PMID: 35567726

Digital Resources/Online E-Resources

4
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
Material Type:
Article
Add to My Research

Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)

Progress in cardiovascular diseases, 2023-07, Vol.79, p.2-11 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0033-0620 ;ISSN: 1873-1740 ;EISSN: 1532-8643 ;DOI: 10.1016/j.pcad.2023.03.001

Digital Resources/Online E-Resources

5
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
Material Type:
Article
Add to My Research

Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)

Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) http://creativecommons.org/licenses/by-nc-nd/4.0 ;ISSN: 0033-0620 ;EISSN: 1532-8643 ;DOI: 10.1016/j.pcad.2023.03.001 ;DOI: 10.5167/uzh-257579

Digital Resources/Online E-Resources

6
Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study
Material Type:
Article
Add to My Research

Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study

Frontiers in cardiovascular medicine, 2023-06, Vol.10, p.1206551-1206551 [Peer Reviewed Journal]

2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella. ;2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella. 2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella ;ISSN: 2297-055X ;EISSN: 2297-055X ;DOI: 10.3389/fcvm.2023.1206551 ;PMID: 37404744

Full text available

7
Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemias
Material Type:
Article
Add to My Research

Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemias

PloS one, 2023-05, Vol.18 (5), p.e0272883-e0272883 [Peer Reviewed Journal]

Copyright: © 2023 Vrablík et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2023 Public Library of Science ;2023 Vrablík et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Vrablík et al 2023 Vrablík et al ;2023 Vrablík et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0272883 ;PMID: 37216363

Full text available

8
Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit
Material Type:
Article
Add to My Research

Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit

International journal of cardiology. Heart & vasculature, 2022-10, Vol.42, p.101117-101117, Article 101117 [Peer Reviewed Journal]

2022 The Authors ;2022 The Authors. ;2022 The Authors. Published by Elsevier B.V. 2022 ;ISSN: 2352-9067 ;EISSN: 2352-9067 ;DOI: 10.1016/j.ijcha.2022.101117 ;PMID: 36118256

Full text available

9
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries
Material Type:
Article
Add to My Research

An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries

European heart journal. Cardiovascular pharmacotherapy, 2022-09, Vol.8 (6), p.539-548 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;COPYRIGHT 2022 Oxford University Press ;ISSN: 2055-6837 ;EISSN: 2055-6845 ;DOI: 10.1093/ehjcvp/pvab052 ;PMID: 34232315

Full text available

10
Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study
Material Type:
Article
Add to My Research

Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study

Frontiers in medicine, 2022-05, Vol.9, p.861419-861419 [Peer Reviewed Journal]

Copyright © 2022 Oreska, Storkanova, Kudlicka, Tuka, Mikes, Krupickova, Satny, Chytilova, Kvasnicka, Spiritovic, Hermankova, Cesak, Rybar, Pavelka, Senolt, Mann, Vencovsky, Vrablik and Tomcik. ;Copyright © 2022 Oreska, Storkanova, Kudlicka, Tuka, Mikes, Krupickova, Satny, Chytilova, Kvasnicka, Spiritovic, Hermankova, Cesak, Rybar, Pavelka, Senolt, Mann, Vencovsky, Vrablik and Tomcik. 2022 Oreska, Storkanova, Kudlicka, Tuka, Mikes, Krupickova, Satny, Chytilova, Kvasnicka, Spiritovic, Hermankova, Cesak, Rybar, Pavelka, Senolt, Mann, Vencovsky, Vrablik and Tomcik ;ISSN: 2296-858X ;EISSN: 2296-858X ;DOI: 10.3389/fmed.2022.861419 ;PMID: 35602501

Full text available

11
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics
Material Type:
Article
Add to My Research

Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics

Frontiers in genetics, 2022-03, Vol.13, p.849267-849267 [Peer Reviewed Journal]

Copyright © 2022 Altschmiedova, Todorovova, Vrablik, and Ceska. ;Copyright © 2022 Altschmiedova, Todorovova, Vrablik, and Ceska. 2022 Altschmiedova, Todorovova, Vrablik, and Ceska ;ISSN: 1664-8021 ;EISSN: 1664-8021 ;DOI: 10.3389/fgene.2022.849267 ;PMID: 35368707

Full text available

12
Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections
Material Type:
Article
Add to My Research

Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections

Expert opinion on drug safety, 2022-03, Vol.21 (3), p.291 [Peer Reviewed Journal]

EISSN: 1744-764X ;DOI: 10.1080/14740338.2022.2043848 ;PMID: 35188012

Digital Resources/Online E-Resources

13
Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?
Material Type:
Article
Add to My Research

Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?

Current atherosclerosis reports, 2022-03, Vol.24 (3), p.161 [Peer Reviewed Journal]

2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. ;EISSN: 1534-6242 ;DOI: 10.1007/s11883-022-00983-2 ;PMID: 35174437

Digital Resources/Online E-Resources

14
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
Material Type:
Article
Add to My Research

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

The Lancet (British edition), 2022-02, Vol.399 (10326), p.719-728 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02001-8 ;PMID: 35101175

Full text available

15
A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins
Material Type:
Article
Add to My Research

A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins

Journal of cardiovascular pharmacology and therapeutics, 2022-01, Vol.27, p.10742484221138284

The Author(s) 2022 ;ISSN: 1074-2484 ;EISSN: 1940-4034 ;DOI: 10.1177/10742484221138284 ;PMID: 36420979

Full text available

16
Statins and Inflammation
Material Type:
Article
Add to My Research

Statins and Inflammation

Current atherosclerosis reports, 2021-12, Vol.23 (12), p.80 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. ;EISSN: 1534-6242 ;DOI: 10.1007/s11883-021-00977-6 ;PMID: 34851454

Digital Resources/Online E-Resources

17
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
Material Type:
Article
Add to My Research

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Current atherosclerosis reports, 2021-10, Vol.23 (10), p.57 [Peer Reviewed Journal]

The Author(s) 2021 ;2021. The Author(s). ;ISSN: 1523-3804 ;EISSN: 1534-6242 ;DOI: 10.1007/s11883-021-00955-y ;PMID: 34345932

Digital Resources/Online E-Resources

18
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
Material Type:
Article
Add to My Research

Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit

Rheumatic & musculoskeletal diseases open, 2021-07, Vol.7 (2), p.e001724 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 2056-5933 ;EISSN: 2056-5933 ;DOI: 10.1136/rmdopen-2021-001724 ;PMID: 34244381

Full text available

19
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
Material Type:
Article
Add to My Research

Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit

RMD Open, 2021-07, Vol.7 (2)

public

Digital Resources/Online E-Resources

20
Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?
Material Type:
Article
Add to My Research

Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?

International journal of molecular sciences, 2021-04, Vol.22 (8), p.4182 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms22084182 ;PMID: 33920733

Full text available

Results 1 - 20 of 47  for All Library Resources

Results 1 2 3 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2009  (5)
  2. 2009 To 2011  (6)
  3. 2012 To 2015  (5)
  4. 2016 To 2019  (8)
  5. After 2019  (22)
  6. More options open sub menu

Resource Type 

  1. Articles  (45)
  2. Books  (2)
  3. More options open sub menu

Language 

  1. Japanese  (5)
  2. Spanish  (1)
  3. More options open sub menu

Suggested New Searches

Ignore my query and look for everything

by this author/creator:

  1. Vrablik, Michal
  2. Vrablik, Michal

Searching Remote Databases, Please Wait